Cargando…

TGFβ Activated Kinase 1 (TAK1) at the Crossroad of B Cell Receptor and Toll-Like Receptor 9 Signaling Pathways in Human B Cells

B cell development and activation are regulated by combined signals mediated by the B cell receptor (BCR), receptors for the B-cell activating factor of the tumor necrosis factor family (BAFF-R) and the innate receptor, Toll-like receptor 9 (TLR9). However, the underlying mechanisms by which these s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szili, Dániel, Bankó, Zsuzsanna, Tóth, Eszter Angéla, Nagy, György, Rojkovich, Bernadette, Gáti, Tamás, Simon, Melinda, Hérincs, Zoltán, Sármay, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011794/ https://www.ncbi.nlm.nih.gov/pubmed/24801688 http://dx.doi.org/10.1371/journal.pone.0096381

Ejemplares similares

Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)

Expression of Concern: TGFβ Activated Kinase 1 (TAK1) at the Crossroad of B Cell Receptor and Toll-Like Receptor 9 Signaling Pathways in Human B Cells
Publicado: (2022)

In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles
por: Pozsgay, Judit, et al.
Publicado: (2016)

Bead Arrays for Antibody and Complement Profiling Reveal Joint Contribution of Antibody Isotypes to C3 Deposition
por: Ayoglu, Burcu, et al.
Publicado: (2014)

Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis
por: Szarka, Eszter, et al.
Publicado: (2018)

Selective inhibition of Toll-like receptor 4 signaling by the small molecule TAK-242
por: Kawamoto, T, et al.
Publicado: (2006)

The Toll-like receptor 4 antagonist TAK-242 protects against chronic pancreatitis in rats
por: Pan, Long-Fei, et al.
Publicado: (2017)

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
por: Di Lorenzo, Antonino, et al.
Publicado: (2020)

Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress
por: Gárate, Iciar, et al.
Publicado: (2014)

TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury
por: Zhang, Yide, et al.
Publicado: (2015)

TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice
por: Hua, Fang, et al.
Publicado: (2015)

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2018)

TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
por: Feng, Yan, et al.
Publicado: (2023)

Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug
por: Samarpita, Snigdha, et al.
Publicado: (2020)

B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota
por: Kreuk, Lieselotte SM, et al.
Publicado: (2019)

Molecular mechanisms of metabotropic GABA(B) receptor function
por: Shaye, Hamidreza, et al.
Publicado: (2021)

Regulation of B1 cell migration by signals through Toll-like receptors
por: Ha, Seon-ah, et al.
Publicado: (2006)

Toll-like receptors in the pathogenesis of human B cell malignancies
por: Isaza-Correa, Johana M, et al.
Publicado: (2014)

TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
por: Ono, Yuko, et al.
Publicado: (2020)

At the crossroads of SUMO and NF-κB
por: Kracklauer, Martin P, et al.
Publicado: (2003)

Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
por: Fan, S., et al.
Publicado: (2020)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
por: Tondo, Giacomo, et al.
Publicado: (2019)

Activation of Toll-like receptor 2 induces B(1) and B(2) kinin receptors in human gingival fibroblasts and in mouse gingiva
por: Souza, Pedro P. C., et al.
Publicado: (2019)

Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
por: Graustein, Andrew D., et al.
Publicado: (2018)

Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
por: Fellner, Avi, et al.
Publicado: (2017)

The Role of IgG Fc Region N-Glycosylation in the Pathomechanism of Rheumatoid Arthritis
por: Gyebrovszki, Balázs, et al.
Publicado: (2022)

Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome
por: Halabi, Samer, et al.
Publicado: (2017)

Porcine B Cell Subset Responses to Toll-like Receptor Ligands
por: Braun, Roman Othmar, et al.
Publicado: (2017)

FAK mediates LPS-induced inflammatory lung injury through interacting TAK1 and activating TAK1-NFκB pathway
por: Chen, Xi, et al.
Publicado: (2022)

Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB(1) Receptor Activation
por: Miklós, Zsuzsanna, et al.
Publicado: (2021)

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
por: Lau, Christina M., et al.
Publicado: (2005)

Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor
por: Freeman, Spencer A., et al.
Publicado: (2015)

TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling
por: Yang, Wanlei, et al.
Publicado: (2021)

Correction: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
Publicado: (2020)

Ubiquitin-Specific Protease 14 Negatively Regulates Toll-Like Receptor 4-Mediated Signaling and Autophagy Induction by Inhibiting Ubiquitination of TAK1-Binding Protein 2 and Beclin 1
por: Min, Yoon, et al.
Publicado: (2017)

A breakthrough-like effect of metformin reduces peripheral resistance to triiodothyronine in euthyroid, non-insulin-resistant, type 2 diabetic patients
por: Kertész, Melinda, et al.
Publicado: (2021)

Recruitment of Cbl-b to B Cell Antigen Receptor Couples Antigen Recognition to Toll-Like Receptor 9 Activation in Late Endosomes
por: Veselits, Margaret, et al.
Publicado: (2014)

Anandamide Concentration-Dependently Modulates Toll-Like Receptor 3 Agonism or UVB-Induced Inflammatory Response of Human Corneal Epithelial Cells
por: Angyal, Ágnes, et al.
Publicado: (2021)

Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
por: Acchioni, Chiara, et al.
Publicado: (2021)

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia
por: Rybka, Justyna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vua7468oajbo6s5j55gv5hpk96